Statins may reduce disease recurrence in patients with ulcerated primary melanoma.

CONCLUSION: Statins commenced before melanoma diagnosis, may reduce the risk of melanoma recurrence, especially in males and those with ulcerated tumours. Clinical trial evaluation of the potential role of statins in improving the prognosis of high-risk melanoma is warranted.
PMID: 32133622 [PubMed - as supplied by publisher]

Source: The British Journal of Dermatology - March 3, 2020 Category: Dermatology Authors: von Schuckmann LA, Khosrotehrani K, Ghiasvand R, Hughes MCB, van der Pols JC, Malt M, Smithers BM, Green AC Tags: Br J Dermatol Source Type: research